Ursprung des Netzwerks ersten Grades von David Sohi
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Private Company | Medical Specialties | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von David Sohi
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PACIFIC SOFTWARE, INC. | Packaged Software | Director/Board Member | |
| A.C. SIMMONDS AND SONS INC | Movies/Entertainment | Director/Board Member | |
| York University | College/University | Undergraduate Degree | |
| University of Toronto | College/University | Undergraduate Degree Doctorate Degree | |
| University of Western Ontario | College/University | Doctorate Degree | |
CardioGenics, Inc.
 CardioGenics, Inc. BiotechnologyHealth Technology CardioGenics, Inc. manufactures biotechnology and medical devices. It develops in-vitro-diagnostics cardiac testing products. The company was founded in 1997 and is headquartered in Mississauga, Canada. | Biotechnology | Director/Board Member | |
| AVIVAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CANADIAN OIL RECOVERY & REMEDIATION ENTERPRISES LTD. | Environmental Services | Director/Board Member | |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
| CARDIOGENICS HOLDINGS INC | Medical Specialties | Director/Board Member | |
Axcelon Biopolymers Corp.
 Axcelon Biopolymers Corp. Electronic Equipment/InstrumentsElectronic Technology Axcelon Biopolymers Corp. provides medical devices for human health applications. It provides devices to those companies which uses nanotechnology to biodegradable polymer design and applications. Its technology includes stent coating, ophthalmology, drug delivery and regenerative medicine. The company is headquartered in Toronto, Canada | Electronic Equipment/Instruments | Chief Executive Officer | |
| Mentra Nova Enterprises, Inc. | President | ||
| Panford Investment Corp. | Corporate Officer/Principal | ||
| Richard Ivey School of Business | College/University | Masters Business Admin | |
| EADA Business School | College/University | Graduate Degree | |
Medicenna Therapeutics, Inc.
 Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Pharmaceuticals: Major | Director/Board Member | |
| MEDICENNA THERAPEUTICS CORP. | Biotechnology | Director/Board Member | |
Globus Technologies
 Globus Technologies Packaged SoftwareTechnology Services Globus Technologies develops mobile and portable technology software. The private company is based in Toronto, Canada. | Packaged Software | President | |
Rx Green Corp.
 Rx Green Corp. BiotechnologyHealth Technology Rx Green Corp. develops biotechnology products. | Biotechnology | President | |
Purple Elephant
 Purple Elephant Miscellaneous Commercial ServicesCommercial Services Purple Elephant provides home care relief to individuals and families for charity. The private company is based in Toronto, Canada. The Canadian company was founded by Aras Azadian. | Miscellaneous Commercial Services | Founder | |
| AVICANNA INC. | Biotechnology | Chairman Founder | |
| PURE GLOBAL CANNABIS INC. | Pharmaceuticals: Other | Chairman | |
| ATLANTIC COASTAL ACQUISITION CORP. | Financial Conglomerates | Director/Board Member |
Statistik
International
| Kanada | 22 |
| Vereinigte Staaten | 4 |
| Hong Kong | 2 |
| Spanien | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 11 |
| Consumer Services | 7 |
| Technology Services | 4 |
| Commercial Services | 3 |
| Finance | 3 |
Operativ
| Director/Board Member | 17 |
| Independent Dir/Board Member | 6 |
| Chairman | 6 |
| President | 6 |
| Chief Executive Officer | 4 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Chandrakant Panchal | 22 |
| Aras Azadian | 7 |
| Yuri Lawryshyn | 3 |
- Börse
- Insiders
- David Sohi
- Unternehmensverbindungen
